This Article Full Text Full Text (PDF) All Versions of this Article: jhc.2008.950287v1 56/7/639    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Salomäki, H. H. Articles by Järveläinen, H. T. PubMed PubMed Citation Articles by Salomäki, H. H. Articles by Järveläinen, H. T. Social Bookmarking                      What's this?

Differential Expression of Decorin by Human Malignant and Benign Vascular Tumors

Henriikka H. Salomäki¹, Annele O. Sainio¹, Mirva Söderström, Sari Pakkanen, Jukka Laine and Hannu T. Järveläinen

Departments of Medical Biochemistry (HHS,AOS,SP,HTJ), Pathology (MS,JL), and Medicine (HTJ), University of Turku, Turku, Finland

Correspondence to: Dr. Hannu Järveläinen, MD, PhD, Turku University Central Hospital, Department of Medicine, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland. E-mail: hannu.jarvelainen{at}utu.fi

An increasing amount of evidence indicates that a small extracellular chondroitin/dermatan sulfate proteoglycan, decorin, is indirectly involved in angiogenesis. Given that angiogenesis is a sine qua non for tumor growth and progression, we attempted to examine whether human malignant vascular tumors differ from human benign vascular tumors in terms of their decorin expression and synthesis. CD31 immunostaining demonstrated that the human malignant vascular tumors Kaposi's sarcoma and angiosarcoma were filled with capillary-like structures, whereas in benign cavernous and capillary hemangiomas, blood vessels were not as abundantly present. By utilizing in situ hybridization and immunocytochemical assays for decorin, we showed that there was no detectable decorin mRNA expression or immunoreactivity within the tumor mass in the Kaposi's sarcoma or angiosarcoma group. Instead, decorin was expressed in the connective tissue stroma lining the sarcoma tissue. In contrast to sarcomas, in hemangiomas, decorin mRNA expression and immunoreactivity were observed also within the tumor mass, particularly in the connective tissue stroma surrounding the clusters of intratumoral blood vessels. Finally, distribution of type I collagen was found to be similar to that of decorin in these tumor tissues. Our findings can be explained with different states of angiogenesis in dissimilar growths. In sarcomas, angiogenesis is extremely powerful, whereas in hemangiomas, angiogenesis has ceased. Thus, decorin is likely to possess a suppressive effect on human tumor angiogenesis in vivo, as previously described by studies using different experimental models. Decorin certainly provides a usable biomarker for distinguishing between benign and malignant vascular tumors in patients. (J Histochem Cytochem 56:639–646, 2008)

Key Words: decorin • type I collagen • sarcoma • hemangioma • angiogenesis

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact

The Journal of Histochemistry & Cytochemistry is owned, published, and licensed by The Histochemical Society © 2008